Your browser doesn't support javascript.
loading
Caffeine intake enhances the benefits of sodium glucose transporter 2 inhibitor.
Hashimoto, Yoshitaka; Tanaka, Muhei; Yamazaki, Masahiro; Nakano, Koji; Ushigome, Emi; Okada, Hiroshi; Oda, Yohei; Nakamura, Naoto; Fukui, Michiaki.
Afiliação
  • Hashimoto Y; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Tanaka M; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Yamazaki M; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Nakano K; Department of Endocrinology and Metabolism, Kyoto Yamashiro General Medical Center, Kyoto, Japan.
  • Ushigome E; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Okada H; Division of Metabolism, Nephrology and Rheumatology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Oda Y; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Nakamura N; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Fukui M; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan. sayarinapm@hotmail.com.
Diabetes Metab Res Rev ; 32(7): 694-699, 2016 10.
Article em En | MEDLINE | ID: mdl-26891133

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cafeína / Diabetes Mellitus Tipo 2 / Transportador 2 de Glucose-Sódio / Taxa de Filtração Glomerular / Estimulantes do Sistema Nervoso Central / Hipoglicemiantes Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Metab Res Rev Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cafeína / Diabetes Mellitus Tipo 2 / Transportador 2 de Glucose-Sódio / Taxa de Filtração Glomerular / Estimulantes do Sistema Nervoso Central / Hipoglicemiantes Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Metab Res Rev Ano de publicação: 2016 Tipo de documento: Article